An Early Stage Diffuse B-Cell Lymphoma within a

Similar documents
Case Report Pleural Mesothelioma Presenting as Periumbilical Metastasis: The First Clinical Documentation

Lung Cancer Treatment Guidelines

Primary -Benign - Malignant Secondary

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

SMALL CELL LUNG CANCER

A Practical Guide to Advances in Staging and Treatment of NSCLC

Neoplasms of the LUNG and PLEURA

Linfoma maligno pulmonar tratado com Nerium oleander. CASE REPORT

Case Report A Cause of Bilateral Chylothorax: A Case of Mesothelioma without Pleural Involvement during Initial Diagnosis

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Kidney Cancer OVERVIEW

Male. Female. Death rates from lung cancer in USA

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Small Cell Lung Cancer

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Thoracoscopy in Pleural Malignant Mesothelioma

HOVON Staging and Response Criteria for Non-Hodgkin s Lymphomas Page 1

Malignant Lymphomas and Plasma Cell Myeloma

Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.

Leukemias and Lymphomas: A primer

Case Report Malignant Mesothelioma Mimicking Invasive Mammary Carcinoma in a Male Breast

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

Received June 18, 2007; Revised August 30, 2007; Accepted August 30, 2007; Published September 17, 2007

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

Update on Mesothelioma

A 32 year old woman comes to your clinic with neck masses for the last several weeks. Masses are discrete, non matted, firm and rubbery on

Radiation Therapy in the Treatment of

J of Evidence Based Med & Hlthcare, pissn , eissn / Vol. 2/Issue 33/Aug. 17, 2015 Page 5063

Post-PET Restaging Cancer Form National Oncologic PET Registry

OBJECTIVES By the end of this segment, the community participant will be able to:

Pediatric Oncology for Otolaryngologists

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA

PET/CT in Lung Cancer

The Need for Accurate Lung Cancer Staging

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

YOUR LUNG CANCER PATHOLOGY REPORT

Survival analysis of 220 patients with completely resected stage II non small cell lung cancer

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14

A912: Kidney, Renal cell carcinoma

Pathology of lung cancer

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

Response Criteria for Malignant Lymphoma Cheson Criteria. Quick Reference Guide

Finding an Appropriate Treatment

Current Status and Perspectives of Radiation Therapy for Breast Cancer

The Di Bella Method (DBM) improves Survival, Objective Response and Performance Status in Breast Cancer

Lung Cancer: Diagnosis, Staging and Treatment

Non-Small Cell Lung Cancer

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.

Avastin: Glossary of key terms

Research Article Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma

Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature

Carcinosarcoma of the Ovary

Case Report Primary Pericardial Mesothelioma: A Rare Entity

Patterns of nodal spread in thoracic malignancies

Interesting Case Series. Periorbital Richter Syndrome

New Evaluation Criteria for Response and Toxicity in Lung Cancer Treatment

Sternotomy and removal of the tumor

Oncology Best Practice Documentation

Lung Cancer Center: How to Achieve JCI

Medullary Renal Cell Carcinoma Case Report

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

Chapter 2 Staging of Breast Cancer

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Lung cancer forms in tissues of the lung, usually in the cells lining air passages.

Something Old, Something New.

Lung Cancer. Understanding your diagnosis

Stage I, II Non Small Cell Lung Cancer

PROTOCOLS FOR TREATMENT OF MALIGNANT LYMPHOMA

Case of the. Month October, 2012

People Living with Cancer

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer

Pleural and Pericardial fluids a one year analysis

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Management of Non-Small Cell Lung Cancer Guide for General Practitioners

Surgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

International Journal of Case Reports in Medicine

How To Treat Lung Cancer At Cleveland Clinic

Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

TUBERCULOSIS PLEURAL EFFUSION - MANAGEMENT

THYROID CANCER. I. Introduction

Lung Cancer Understanding your diagnosis

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

3.0 With final Comments for presentation at Sub Group Meeting

亞 東 紀 念 醫 院 Follicular Lymphoma 臨 床 指 引

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

Correspondence should be addressed to Heinz-Jakob Langen;

Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines

What is neuroendocrine cervical cancer?

Case Report Laser Vision Correction on Patients with Sick Optic Nerve: A Case Report

Transcription:

Diagnostic and Therapeutic Endoscopy, Vol. 6, pp. 179-182 Reprints available directly from the publisher Photocopying permitted by license only (C) 2000 OPA (Overseas Publishers Association) N.V. Published by license under the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in Malaysia. An Early Stage Diffuse B-Cell Lymphoma within a Visible Site of Bronchofiberscope Accompanied by Peripheral Lung Cancer HIDEAKI SHIMATANI a *, KINNYA FURUKAWA a, YOSHIROU EBIHARA b, HIROMI SERIZAWA b, MASAHIRO TSUBOI a, AKIHIKO OGATA a, CHIMORI KONAKA and HARUBUMI KATO adepartment of 1st Surgery, bdepartment of Pathology, Tokyo Medical University, 6-7-1, Nishishinjyuku, Shinjyuku-ku, Tokyo 160-0023, Japan (Received 12 January 2000; In finalform 7 March 2000) We report a case ofnon-hodgkin s lymphoma found at the orifice ofright B2 accompanied by peripheral lung cancer in a 66-year-old asymptomatic man. Chest X-ray films showed a mass shadow in the left lower lung field. Transbronchial lung biopsy of left $9 demonstrated squamous cell carcinoma. Simultaneously wall thickening at the orifice of the right B2 was found coincidentally. The biopsy specimen from that site showed non-hodgkin s lymphoma (diffuse B-cell type). After left lower lobectomy, systemic chemotherapy was performed. It is rare for malignant lymphoma to be recognized bronchofiberscopically. Keywords: BALT, Lung, Non-Hodgkin s lymphoma, Triple malignant disease 1. INTRODUCTION Endobronchial involvement of malignant lymphoma is extremely rare [1], and primary lymphomas in pulmonary parenchymal tissue account only for 0.45% of all pulmonary malignancies [2]. Thus, we report a case of malignant lymphoma that was entirely visible bronchoscopically and was accompanied by peripheral lung cancer. 2. CASE REPORT A 66-year-old man who suffered from laryngeal cancer underwent microsurgery in October, 1997 followed by radiotherapy. The histologic type was moderately differentiated squamous cell carcinoma and the clinical stage was T lanom0. In August, 1999, he was referred to our department for detailed examinations for an abnormal shadow on chest * Corresponding author. Tel.: +81-3-3342-6111. Fax: +81-3-3349-0326. 179

180 H. SHIMATANI et al. X-ray film (Fig. 1). His past history was noncontributory apart from his laryngeal cancer. He had never smoked and was asymptomatic. Physical examinations, including lymphonode palpation, showed no abnormalities. A complete blood count revealed; hemoglobin, 14.0 g/dl; leukocyte count, 9.2 103/mm 3 with 70.6% neutrophils, 1.8% eosinophils, 0.2% basophils, 21.3 lymphocytes and 6.1% monocytes; platelet count 206 103/mm3. Serum chemistry showed no abnormality, including tumor markers. CT scan revealed an irregular mass in left $9 (Fig. 2). Lymphadenopathy was seen in the hilar and subcarinal regions. To obtain a definitive diagnosis, transbronchial lung biopsy was performed and the biopsy specimen showed a squamous cell carcinoma of the peripheral lung. Simultaneously a 2 3 mm area of thickened bronchial wall was found at the orifice ofright B2 (Fig. 3). Immunohistochemical staining as well as hematoxylin and eosin staining for the biopsy specimen from this small lesion were performed (Fig. 4). Findings were negative for LCA, cytokeratin, CG- A, anti-cd43 and CD45RO. Since findings were positive for anti-ln-3, anti-cd20 and anti-cd79, a definitive diagnosis of diffuse B-cell type non- Hodgkin s lymphoma was made. A systemic survey, including abdominal and brain CT, bone and Gascintigraphy, showed no metastatic lesions. Systemic chemotherapy, using cisplatin and etoposide was performed and was effective not only for carcinoma but also for lymphoma (Fig. 5(a)). After that, a left lower lobectomy with lymph node dissection via a left thoracotomy was performed. No pleural effusion, adhesion or dissemination were seen. Gross pathologic examination of the resected tumor indicated that it measured 2.5 2.4 2.5 cm FIGURE Chest X-ray film on admission showing a mass shadow in the left lower lung field (arrow). FIGURE 2 Chest CT scan showing a tumorous lesion in left $9. FIGURE 3 Bronchofiberscopy found a wall thickening of the orifice of right B2 unexpectedly.

EARLY STAGE PULMONARY LYMPHOMA 181 FIGURE 4 Histological stain of the endobronchial lesion shows proliferation of slightly atypical lymphocytes. in size. The pathological report described a moderately differentiated primary squamous cell carcinoma of left $9. Lymph node metastases were proven in subcarinal, hilar and interlobular nodes pathologically. Adjuvant chemotherapy, consisting of cisplatin, vinorelbine and prednisolone, was added. Bronchoscopy proved complete remission of the lymphoma cytologically and pathologically (Fig. 5(b)). 3. DISCUSSION Most cases of primary pulmonary lymphoma are non-hodgkin s type. They have a solitary nodule, mass or infiltration on chest X-ray or scanning and seldom involve [3] endobronchial tissue, particularly the region visualized by bronchofiberscopy. In this case, bronchoscopy for the examination of the peripheral cancer unexpectedly discovered a tiny lesion at the orifice of B2 that was negative on the chest radiograph. Immunohistochemical stainings proved that this tumor consisted of B-cell features. A hematoxylin and eosin staining showed proliferation of somewhat atypical and large lymphocytes with notched nuclei. These findings are common to diffuse B-cell type non-hodgkin s lymphomas. Lymphomas that appear to arise from closely related bronchus-associated lymphoid tissue are known as BALT. BALTs have a tendency to remain localized in the lung for long periods [4]. This case FIGURE 5 Bronchoscopical changes of the lymphoma along with treatments. (a) Pre-operative chemotherapy for the carcinoma was also effective for the lymphoma: a reddening of the mucosa could be observed but the tumor mass had disappeared. (b) No malignancy was proven cytologically or pathologically after two courses of chemotherapy, with redness in the mucosa. might have been a BALT but we could not prove it, as the biopsy specimen was insufficient to assess centrocyte-like cells or lymphoepithelial lesions [5]. The clinical stage of this case was IE because the diagnostic images showed no abnormality outside the thoracic cavity. Although there is no definition for early stage lymphoma in a strict sense, this case might be considered to be early stage lymphoma because of its bronchoscopical findings.

182 H. SHIMATANI et al. cedure was contraindicated. We gave therapeutic priority to the squamous cell carcinoma. Fortunately adjuvant chemotherapies were effective for the lymphoma also. Nevertheless strict follow-up is essential. Endobronchial echogram after therapy could not exclude the possibility of residual lymphoma just beneath the bronchial mucosa (Fig. 6). As stated above, we report a case of minute lymphoma completely visible via a bronchofiberscope, accompanied by peripheral lung cancer. This case might be an extremely rare triple primary disease. FIGURE 6 Endobronchial echogram after two courses of chemotherapies showing a hypoechoic layer just beneath the mucosa (arrow). The prognosis of curatively resected primary pulmonary B-cell lymphomas is satisfactory. On the other hand, the prognosis of advanced lung cancer is much worse and surgical treatment is the first option for both neoplasms. Thus, bilateral thoracotomy might be the best treatment from the point of view of curability. However, because of age, PS and pulmonary function, a bilateral pro- References [1] Vieta, J.O. and Craver, L.F. Intrathoracic manifestations of the lymphotoid disease. Radiology 1941; 37:138-159. [2] Papaioannou, N.A. and Watson, W.L. Primary lymphoma of the lung. An appraisal ofits natural history and a comparison with other localized lymphomas. J. Thorac. Cardiovasc. Surg. 1965; 49: 373-387. [3] Cordier, J., Chailleux, E., Lauque, D. et al. Primary pulmonary lymphomas. A clinical study of 70 cases in nonimmunocompromised patients. Chest 1993; 103: 201-208. [4] Herbert, A., Wright, D.H., Isaacson, P.G. et al. Primary pulmonary lymphoma of the lung: histopathologic and immunologic evaluation of nine cases. Him. Pathol. 1984; 15:415-422. [5] Isaacson, P. and Wright, D.H. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53: 2515-2524.

MEDIATORS of INFLAMMATION The Scientific World Journal Gastroenterology Research and Practice Diabetes Research International Endocrinology Immunology Research Disease Markers Submit your manuscripts at BioMed Research International PPAR Research Obesity Ophthalmology Evidence-Based Complementary and Alternative Medicine Stem Cells International Oncology Parkinson s Disease Computational and Mathematical Methods in Medicine AIDS Behavioural Neurology Research and Treatment Oxidative Medicine and Cellular Longevity